波多野结衣办公室双飞_制服 丝袜 综合 日韩 欧美_网站永久看片免费_欧美一级片在线免费观看_免费视频91蜜桃_精产国品一区二区三区_97超碰免费在线观看_欧美做受喷浆在线观看_国产熟妇搡bbbb搡bbbb_麻豆精品国产传媒

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Reporter's Journal

Conquering malaria remains a daunting dilemma, but there's hope

By Chris Davis | China Daily USA | Updated: 2017-04-27 11:18
Share
Share - WeChat

The war against malaria has made progress over the past decade, but there is still a long way to go, and Chinese researchers are leading the way on more than one front.

Roughly half of the world's population - 3 billion people - still remains at risk.

In 2006, there were 266 million cases a year leading to 750,000 deaths, according to the World Health Organization.

By 2015, the numbers had diminished, but remained huge - 212 million cases, 429,000 deaths.

And a staggering 90 percent of all cases are in Africa.

Dr Deng Changsheng, manager of the department of science and technology at Guangzhou University of Chinese Medicine, told a group of 27 journalists visiting from Africa recently, that strategy used to cause a major decline in malarial regions of China is showing promise in Africa.

The approach is called fast elimination of malaria by source eradication (FEMSE). It involves mass drug administration (MDA) of artemisinin-based combination therapies (ACT) - in other words, clearing an affected population of the malarial parasites by mass drug administration.

Artemisinin, by the way, is the drug that won 85-year-old Chinese pharmacologist Tu Youyou the 2015 Nobel Prize for Medicine. She had mined the recipe, derived from the sweet wormwood plant, from the annals of ancient Chinese medicine. Today it saves hundreds of thousands of lives a year in Africa alone.

The drug has not been cheap, but Deng said the cost could be brought to as low as $15 per person over the next decade. Today it's about $40, according to Deng.

Thanks to a worldwide push, ACT treatments rose from 187 million in 2010 to 311 million in 2015.

The big fear facing the effort right now is that the parasites are showing signs of developing a resistance to artemisinin, the same way some strains of tuberculosis are shunning off some of modern medicine's most potent antibiotics.

"The spread of artemisinin resistance in Africa would be a major setback in the fight against malaria, as ACT is the only effective and widely used anti-malarial treatment at the moment," writes Professor Arnab Pain of King Abdullah University of Science and Technology in the current issue of the New England Journal of Medicine.

"Therefore it is very important to regularly monitor artemisinin resistance on a worldwide scale," he added.

The study, led by Jun Cao of the Institute for Parasitic Diseases in China, found drug-resistant malarial parasites in a Chinese patient who had been in Equatorial Guinea and returned to China. The ACT therapy, which usually takes three days to rid the patient of the disease, took five days in this case.

This "partial resistance", they said, has been noted in other parts of Southeast Asia, and the great fear is that "partial" morphs into "complete".

"This is one of the great challenges facing us in the fight against malaria," the World Health Organization says on its website.

The holy grail of that fight, of course, remains a vaccine, and The Associated Press reports that three African nations have just been chosen to test the world's first malaria vaccine.

WHO announced Monday that Ghana, Kenya and Malawi will begin piloting an injectable vaccine next year with hundreds of thousands of young children, who have been at highest risk of death.

The vaccine, which has partial effectiveness, has the potential to save tens of thousands of lives if used with existing measures, WHO's regional director for Africa, Dr Matshidiso Moeti, said in a statement. The challenge is whether impoverished countries can deliver the required four doses of the vaccine for each child.

The vaccine will be tested on children 5 to 17 months old to see whether its protective effects shown so far in clinical trials can hold up under real-life conditions. At least 120,000 children in each of the three countries will receive the vaccine, which has taken decades of work and hundreds of millions of dollars to develop.

Kenya, Ghana and Malawi were chosen for the vaccine pilot because all have strong prevention and vaccination programs but continue to have high numbers of malaria cases, WHO said. The countries will deliver the vaccine through their existing vaccination programs.

WHO is hoping to wipe out malaria by 2040, despite the increasing resistance problems to both drugs and insecticides used to kill mosquitoes.

The vaccine was developed by GlaxoSmithKline, and the $49 million for the first phase of the pilot is being funded by the global vaccine alliance GAVI, UNITAID and Global Fund to Fight AIDS, Tuberculosis and Malaria.

Contact the writer at chrisdavis@chinadailyusa.com.

 

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
波多野结衣办公室双飞_制服 丝袜 综合 日韩 欧美_网站永久看片免费_欧美一级片在线免费观看_免费视频91蜜桃_精产国品一区二区三区_97超碰免费在线观看_欧美做受喷浆在线观看_国产熟妇搡bbbb搡bbbb_麻豆精品国产传媒
亚洲视频一区在线观看| 高潮精品一区videoshd| www.17c.com喷水少妇| 欧美在线一区二区| 中文字幕一区免费在线观看| 精品一区二区国语对白| 中文字幕人妻一区二区| 日韩一区二区免费在线观看| 性做久久久久久免费观看| 国产高潮失禁喷水爽到抽搐| 欧美私人免费视频| 亚洲综合色成人| 国产a√精品区二区三区四区| 在线亚洲免费视频| 亚洲黄色av一区| 91麻豆精品视频| 欧美亚洲国产一区二区三区 | 精品视频在线免费看| 亚洲男同1069视频| 91免费国产在线观看| 欧美色综合天天久久综合精品| 亚洲狠狠丁香婷婷综合久久久| 色哟哟网站在线观看| 欧美三级日韩三级| 天天av天天翘天天综合网色鬼国产| 无码人妻精品一区二区三| 欧美另类videos死尸| 香蕉久久夜色精品国产使用方法| 人妻体内射精一区二区三区| 欧美一卡二卡三卡| 久久99精品国产.久久久久久 | 亚洲成人777| 日韩免费高清一区二区| 9191久久久久久久久久久| 婷婷久久综合九色综合伊人色| 国产乱了高清露脸对白| 337p日本欧洲亚洲大胆精品| 国产一区二区网址| 国内偷拍精品视频| 亚洲韩国一区二区三区| 草草地址线路①屁屁影院成人| 精品成人私密视频| 成人免费视频免费观看| 欧美色图天堂网| 日韩av电影天堂| 人成免费在线视频| 亚洲人成网站色在线观看| avtt中文字幕| 欧美精品一区二区三区四区| 国产成人综合网站| 欧美视频一区二区在线观看| 亚洲高清视频在线| 无码少妇一区二区| 亚洲欧美日韩国产手机在线 | 亚洲蜜臀av乱码久久精品| 国产精品一区二区在线免费观看| 日韩精品一区二区三区视频在线观看| 激情欧美一区二区| 在线欧美一区二区| 日韩福利电影在线| 黑人操日本美女| 亚洲成人在线网站| 亚洲最大成人综合网| 亚洲精品午夜久久久| 日本黄色特级片| 中文字幕一区二区三区精华液| 国产日韩视频一区| 国产午夜亚洲精品羞羞网站| 日本人dh亚洲人ⅹxx| 久久中文字幕电影| 91蜜桃免费观看视频| 欧美精品一区二区三| 91丨九色porny丨蝌蚪| 日韩美女在线视频| 日韩在线不卡av| 开心激情五月网| 亚洲国产一区二区在线播放| 高清国产在线观看| 亚洲国产精品一区二区www在线| 欧美 日韩 成人| 亚洲综合久久av| 日本精品久久久久中文| 亚洲国产三级在线| 国产成人av免费在线观看| 日韩高清中文字幕一区| 色婷婷综合中文久久一本| 美女网站在线免费欧美精品| 岛国毛片在线观看| 久久av老司机精品网站导航| 欧美少妇bbb| 国产成人综合自拍| 日韩欧美一二三区| 国产男女无遮挡猛进猛出| 欧美激情资源网| 中文字幕一区二区三区人妻| 亚洲黄色免费电影| 一区二区视频免费看| 激情国产一区二区| 欧美一区二区在线播放| 人妻换人妻仑乱| 国产欧美日韩视频在线观看| 右手影院亚洲欧美| 亚洲国产婷婷综合在线精品| 一本高清dvd不卡在线观看| 国内精品伊人久久久久av影院| 51久久夜色精品国产麻豆| 91论坛在线播放| 亚洲欧洲精品一区二区精品久久久| 中文字幕在线观看免费高清| 日韩不卡一区二区| 欧美日韩久久久一区| 97久久超碰国产精品| 国产精品久久久久一区| 国产三级在线观看完整版| 麻豆一区二区99久久久久| 制服丝袜在线91| 风韵丰满熟妇啪啪区老熟熟女| 亚洲欧美一区二区三区极速播放| 情侣偷拍对白清晰饥渴难耐| 精品一区二区国语对白| 精品国产乱码久久久久久图片 | 成人av片在线观看| 日本一区二区三区dvd视频在线| 人妻aⅴ无码一区二区三区| 蜜桃久久精品一区二区| 欧美一级一区二区| jlzzjizz在线播放观看| 性做久久久久久免费观看| 欧美日韩精品欧美日韩精品一综合| av午夜一区麻豆| 亚洲欧洲精品成人久久奇米网| 一区视频免费观看| 波多野结衣精品在线| 亚洲天堂成人在线观看| 色一情一乱一乱一91av| 成人精品小蝌蚪| 亚洲三级久久久| 欧美亚洲禁片免费| 动漫av在线免费观看| 午夜精品国产更新| 日韩一区二区视频| 亚洲熟妇一区二区三区| 美女一区二区视频| 久久综合av免费| 欧美成人久久久免费播放| 国产精品一二三区在线| 中文字幕 久热精品 视频在线| 人人澡人人澡人人看| jvid福利写真一区二区三区| 亚洲女子a中天字幕| 欧美色爱综合网| 成人午夜精品无码区| 蜜臀久久99精品久久久画质超高清 | 日韩精品乱码免费| 精品国产青草久久久久福利| 长河落日免费高清观看| 丁香婷婷综合色啪| 亚洲精品成人悠悠色影视| 欧美另类高清zo欧美| 国产白嫩美女无套久久| 韩国女主播成人在线观看| 国产精品免费人成网站| 欧美中文字幕一区二区三区亚洲| 美国黄色一级视频| 九九视频精品免费| 中文字幕中文字幕一区二区 | 女同久久另类69精品国产| 成人a级免费电影| 亚洲一二三四区不卡| 精品国产91洋老外米糕| 好吊日在线视频| 国产精品嫩草69影院| 美女网站视频久久| 中文字幕在线不卡一区二区三区| 欧美日韩一区二区三区视频| 精品国产av色一区二区深夜久久| 国产尤物一区二区| 亚洲精品欧美专区| 精品日产卡一卡二卡麻豆| 亚洲综合视频网站| 白嫩情侣偷拍呻吟刺激| 国产在线播放一区二区三区| 亚洲免费三区一区二区| 日韩精品在线看片z| 欧美老熟妇一区二区三区| 50一60岁老妇女毛片| 国产一区二区三区日韩| 亚洲美女一区二区三区| 精品美女一区二区| 色狠狠色狠狠综合| 法国空姐电影在线观看| 99视频在线精品| 免费高清成人在线| 中文字幕一区二区三区色视频 | 懂色av粉嫩av蜜乳av| 中文字幕亚洲不卡| 国产呦萝稀缺另类资源| 最新欧美精品一区二区三区| 欧美大尺度电影在线| 一本久道中文字幕精品亚洲嫩|